Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Registry With the Aim to Identify Characteristics of Atrial Conduction and Risk of Recurrence in Patients With Atrial Fibrillation Undergoing Ablation for Atrial Fibrillation

NCT03075930 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT03075930
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03075930 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Registry With the Aim to Identify Characteristics of Atrial Conduction and Risk of Recurrence in Patients With Atrial Fibrillation Undergoing Ablation for Atrial Fibrillation
Lead sponsor
Maastricht University Medical Center
Phase
Observational
Overall status
Unknown status
Start date
January 12, 2017
Completion date
January 31, 2023
Enrollment
1,250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation (paroxysmal), atrial fibrillation common gene variants, atrial fibrillation recurrent